Image:
The biotech firm has achieved global recognition with its DNA sequencing devices used for identifying and tracking the spread of Covid-19 variants.
Oxford Nanopore Technologies has debuted on the London Stock Exchange to strong investor demand as shares in the former Woodford favourite rose more than 40% on open.
The biotech firm set an offer price of 425 pence per share, which would have given the firm a total market capitalisation of approximately £3.4bn. However, the stock opened considerably higher at 545...
To continue reading this article...
Join Professional Adviser
- Unlimited access to real-time news, industry insights and market intelligence.
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters.
- Make smart business decisions with the latest developments in regulation, investing retirement and protection.
- Tap into our community intellignece through our regular Pro Adviser poll.
- Be the first to hear about our events and awards programmes.
